Retrospective evaluation of our 68 pediatric patients diagnosed with inflammatory bowel disease

Purpose:The purpose of our study is to determine demographic, clinical and laboratory, result and response to the treatment qualities by evaluating our patients followed-up due to IBD diagnosis retrospectively and determine the differences regarding IBD subgroups. Materials and methods: This study was carried out by examining the file records of 68 children between 0-18 years of age diagnosed with IBD in the Pediatric Gastroenterology Polyclinic of Akdeniz University between March 20014 and March 2016. Patients' age, gender, endoscopy findings, histopathology findings, laboratory results during the diagnosis and follow-up, complaints, treatments that they have received and are still continuing, and accompanying disease presence have been examined and compared. Results:The mean age of 68 patients with IBD diagnosed was 11.53 ± 2.32 and M / F was 1.45. Thirty three (48.52%) are patients diagnosed with Crohn Disease (CD), 27 (39.70%) are diagnosed with ulcerative colitis (UC) and 8 (11.76%) are diagnosed with indeterminate colitis (IC). During inital diagnosis and after treatment, it is seen that there is improvement in all parameters except Hb including CRP, Hb, WBC, PLT albumin and the difference is statistically significant (p<0.05). Most of our patients diagnosed with CD, UC and IC are monitored in remission. Conclusion: It is found out that CD is seen more frequently in our region in pediatric age group than UC is seen in western countries. At the same time in patients with IBD timely and appropriate treatment could effectively controll the diseasee activity. Pam Med J 2018;11(1):11-17